Chun Liang
Impact in
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 8
- Angiogenesis and VEGF in Cancer 6
- Natural product bioactivities and synthesis 6
- Immunology 13
- Atherosclerosis and Cardiovascular Diseases 9
- Co-authors
- Zonggui Wu (26 shared papers)Yangxin Li (12 shared papers)Zhiqing He (28 shared papers)Yanli Wang (7 shared papers)Bin Liu (7 shared papers)Bing Yan (5 shared papers)Xiyong Yu (7 shared papers)Xiangbin Pan (8 shared papers)
- Journals
- Atherosclerosis (4 papers)Microvascular Research (3 papers)Evidence-based Complementary and Alternative Medicine (3 papers)International Journal of Molecular Medicine (2 papers)Journal of Atherosclerosis and Thrombosis (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Chun Liang
88 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 119
- Clinical Biochemistry 207
- Cancer Research 337
- Cardiology and Cardiovascular Medicine 396
- Molecular Biology 1.2k
- Complementary and alternative medicine 127
Countries citing papers authored by Chun Liang
This map shows the geographic impact of Chun Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Liang more than expected).
Fields of papers citing papers by Chun Liang
This network shows the impact of papers produced by Chun Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Liang. The network helps show where Chun Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chun Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 232 | |
| 2 | 2020 | 161 | |
| 3 | 2011 | 148 | |
| 4 | 2016 | 145 | |
| 5 | 2008 | 140 | |
| 6 | 2019 | 123 | |
| 7 | 2005 | 117 | |
| 8 | 2019 | 100 | |
| 9 | 2010 | 97 | |
| 10 | 2009 | 93 | |
| 11 | 2016 | 91 | |
| 12 | 2009 | 89 | |
| 13 | 2021 | 86 | |
| 14 | 2020 | 84 | |
| 15 | 2004 | 82 | |
| 16 | 2011 | 81 | |
| 17 | 2009 | 51 | |
| 18 | 2019 | 51 | |
| 19 | 2016 | 45 | |
| 20 | 2016 | 40 |
About Chun Liang
Chun Liang is a scholar working on Molecular Biology, Immunology, Surgery, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 91 papers that have together received 2.7k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (9 papers), Extracellular vesicles in disease (8 papers), Angiogenesis and VEGF in Cancer (6 papers), Natural product bioactivities and synthesis (6 papers), Traditional Chinese Medicine Analysis (5 papers), MicroRNA in disease regulation (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Coronary Interventions and Diagnostics (4 papers). The work is most often cited by research in Clinical Biochemistry (207 citations), Cancer Research (337 citations), Cardiology and Cardiovascular Medicine (396 citations), Molecular Biology (1.2k citations) and Complementary and alternative medicine (127 citations). Chun Liang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zonggui Wu, Yangxin Li, Zhiqing He, Yanli Wang, Bin Liu, Bing Yan, Xiyong Yu, Xiangbin Pan, Yusheng Ren and Yao‐Hua Song. Their work appears in journals such as Atherosclerosis, Microvascular Research, Evidence-based Complementary and Alternative Medicine, International Journal of Molecular Medicine and Journal of Atherosclerosis and Thrombosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.